Psychedelic Drug in Early Stages of Development Could Have Potential for Postpartum Depression
Existing treatments for post-partum depression take up to 8 weeks and often separate the mother from her baby for long periods of time, creating even more stress.
Field Trip Health (FTRP) is developing a proprietary psychedelic to change this.
The formulation, FT-104, could be administered in just one day and lasts 2-3 hours shorter than pure psilocybin. The compound leaves the mother’s system in just 24 hours, allowing her to safely breastfeed again.
FT-104 is currently in preclinical evaluation with phase I trials expected to begin in Q1 of next year.